Gencitabine and carboplatin as first-line therapy in advanced/metastatic NSCLC

被引：0
|
作者：
Savio, G. [1 ]
Laudani, A. [1 ]
Usset, A. [1 ]
Leonardi, V. [1 ]
Pepe, A. [1 ]
Palmisano, V. [1 ]
Agostara, B. [1 ]
机构：
[1] Hosp M Ascoli ARNAS CIVICO, Dept Oncol, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [31] Treatment options after first-line immunotherapy in metastatic NSCLC
    Santos, Edgardo S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 221 - 228
  • [32] Optimal first-line therapy for NSCLC with EGFR mutations
    Joel W. Neal
    Lecia V. Sequist
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 71 - 72
  • [33] Atezolizumab as first-line therapy in elderly patients with NSCLC
    Franke, Katharina
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (03) : 75 - 75
  • [34] Atezolizumab as first-line therapy in elderly patients with NSCLC
    Franke, Katharina
    [J]. PNEUMOLOGIE, 2024, 78 (05): : 287 - 287
  • [35] NSCLC: Pembrolizumab also suitable as First-Line Therapy
    Rukavina, Marion
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (04)
  • [36] Choice of first-line therapy in metastatic melanoma
    Gibney, Geoffrey T.
    Atkins, Michael B.
    [J]. CANCER, 2019, 125 (05) : 666 - 669
  • [37] Beyond first-line NSCLC therapy: chemotherapy or erlotinib?
    Paz-Ares, Luis
    [J]. LANCET ONCOLOGY, 2012, 13 (03): : 225 - 227
  • [38] First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin
    Kakolyris, S
    Kourousis, C
    Koukourakis, M
    Androulakis, N
    Vamvakas, L
    Agelaki, S
    Hatzidaki, D
    Samonis, G
    Tsiftsis, D
    Georgoulias, V
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 568 - 572
  • [39] Randomized, phase 2 study of carboplatin and pemetrexed with or without pembrolizumab as first-line therapy for advanced NSCLC: KEYNOTE-021 cohort G
    Langer, C.
    Gaddgeel, S. M.
    Borghaei, H.
    Papadimitrakopoulou, V. A.
    Patnaik, A.
    Powell, S.
    Gentzler, R. D.
    Martins, R. G.
    Stevenson, J. P.
    Jalal, S. I.
    Panwalkar, A.
    Yang, J. C-H.
    Gubens, M. A.
    Sequist, L. V.
    Awad, M. M.
    Fiore, J. J.
    Ge, Y.
    Raftopoulos, H.
    Gandhi, L.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [40] NAB-PACLITAXEL IN COMBINATION WITH CARBOPLATIN AS FIRST-LINE THERAPY IN DIABETIC PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Hirsh, Vera
    Owen, Scott
    Ko, Amy
    Renschler, Markus F.
    Socinski, Mark A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S584 - S584
12345